Breaking News Instant updates and real-time market news.

MTSI

Macom

$22.96

-0.36 (-1.54%)

, INTC

Intel

$48.45

-0.41 (-0.84%)

07:03
08/14/18
08/14
07:03
08/14/18
07:03

Macom downgraded to Underweight with $21 price target at JPMorgan

JPMorgan analyst Harlan Sur downgraded Macom Technology Solutions (MTSI) to Underweight with an unchanged price target of $21. With the stock above his price target, the analyst believes the market is already discounting "strong forward earnings power." The analyst also see the potential for margin pressures on current generation discrete Macom-based white box transceiver reference designs for 100G CWDM4 modules amid competition from Intel (INTC), Applied Optoelectronics (AAOI), and InnoLight.

MTSI

Macom

$22.96

-0.36 (-1.54%)

INTC

Intel

$48.45

-0.41 (-0.84%)

AAOI

Applied Optoelectronics

$42.34

-0.16 (-0.38%)

  • 14

    Aug

  • 16

    Aug

  • 20

    Aug

  • 28

    Aug

  • 12

    Sep

MTSI Macom
$22.96

-0.36 (-1.54%)

05/02/18
CHLM
05/02/18
NO CHANGE
Target $31
CHLM
Buy
Macom price target lowered to $31 from $36 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Macom to $31 from $36 following quarterly results. The analyst reiterates a Buy rating on the shares.
08/14/18
JPMS
08/14/18
DOWNGRADE
Target $21
JPMS
Underweight
Macom downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Harlan Sur downgraded Macom Technology Solutions to Underweight with an unchanged price target of $21.
08/01/18
LOOP
08/01/18
NO CHANGE
LOOP
Loop Capital says Macom comments suggest Applied Optoelectronics, Finisar risk
Loop Capital analyst James Kisner noted that Macom (MTSI) said on its earnings call that last quarter it expanded its roster of white-box transceiver partners and launched its Data Center solutions business. He quotes the company as having said that its agreement with a new customer "enables a new high-volume optical manufacturer to enter the business of delivering fully-qualified CWDM4 transceivers to cloud service providers from their new 400,000-square-foot manufacturing facility." Kisner said the comments suggest a significant risk to the data center optics businesses of Applied Optoelectronics (AAOI) and Finisar (FNSR) now appears to be realized, as customers such as Amazon (AMZN) can effectively "cut out the middlemen" from the module assembly business. About 80% of both Applied's and Finisar's sales come from datacom transceivers, which is business most directly threatened by this development, added Kisner.
08/01/18
CHLM
08/01/18
NO CHANGE
Target $26
CHLM
Buy
Macom price target lowered to $26 from $31 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Macom to $26 from $31 after largely in-line results/guide. The analyst reiterates a Buy rating on the shares.
INTC Intel
$48.45

-0.41 (-0.84%)

08/10/18
GSCO
08/10/18
UPGRADE
Target $21
GSCO
Neutral
AMD upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Toshiya Hari upgraded AMD (AMD) to Neutral from Sell and raised his price target for the shares to $21 from $13.25. The chipmaker closed yesterday down 48c to $19.10. Intel's (INTC) struggles with 10nm process technology make it increasingly harder to argue for a bear thesis, even following the recent rally in the shares, Hari tells investors in a research note. The analyst admits, however, that he still has concerns related to AMD's graphics processing unit business given the continued decline in cryptocurrency mining demand and increased competition from Nvidia (NVDA). Nevertheless, the delay in Intel's new products will allow AMD to gain share in not only client computer processing units, but also in the "lucrative" server CPU market, Hari contends. He believes this makes for a balanced risk/reward profile on AMD shares.
08/10/18
GSCO
08/10/18
DOWNGRADE
GSCO
Sell
Intel downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Toshiya Hari downgraded Intel (INTC) to Sell from Neutral and lowered his price target for the shares to $44 from $49. The chipmaker closed yesterday up 18c to $50.14. Hari coupled the downgrade with an upgrade of AMD (AMD) to Neutral from Sell. Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. He expects a worsening product mix in the near-term, ramp in 10nm costs and growing depreciation to drive margin pressure and Intel's earnings below consensus expectations. Hari sees downside risk in the shares.
08/10/18
08/10/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Sell from Neutral at Goldman Sachs with analyst Toshiya Hari saying Intel's struggles with 10nm process technology makes the analyst incrementally more negative on the company's competitive positioning and margin outlook. 2. Booking Holdings (BKNG) downgraded to Neutral from Buy at Citi and UBS as well as Neutral from Overweight at JPMorgan. 3. Sysco (SYY) downgraded to Sell from Hold at Pivotal Research with analyst Ajay Jain saying he believes the move up in the stock over the past three months is inconsistent with growing industry headwinds as well as Sysco's company-specific issues. 4. Campbell Soup (CPB) downgraded to Underweight from Neutral at JPMorgan with analyst Ken Goldman saying he agrees with activist Third Point that Campbell's best option is to sell the company; however, he sees a sale as an unlikely outcome. 5. Redfin (RDFN) downgraded to Neutral from Buy at DA Davidson with analyst Tom White citing its Q2 results and below-consensus Q3 guidance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/18
08/10/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS INTEL, UPGRADES AMD: Goldman Sachs analyst Toshiya Hari downgraded Intel (INTC) to Sell from Neutral and lowered his price target for the shares to $44 from $49. Hari coupled the downgrade with an upgrade of AMD (AMD) to Neutral from Sell. Intel's struggles with 10nm process technology made the analyst incrementally more negative on the company's competitive positioning and margin outlook. He expects a worsening product mix in the near-term, ramp in 10nm costs and growing depreciation to drive margin pressure and Intel's earnings below consensus expectations. The delay in Intel's new products will allow AMD to gain share in not only client computer processing units, and also in the "lucrative" server CPU market, Hari contended. He believes this makes for a balanced risk/reward profile on AMD shares. In late morning trading, Intel is down 2.5% and AMD is up fractionally. BOOKING HOLDINGS DOWNGRADED AT MULTIPLE FIRMS: UBS analyst Eric Sheridan downgraded Booking Holdings (BKNG) to Neutral from Buy and lowered his price target for the shares to $2,060 from $2,320 following the company's Q2 results. JPMorgan analyst Doug Anmuth downgraded Booking Holdings to Neutral from Overweight and lowered his price target for the shares to $2,070 from $2,385. Additionally, Citi analyst Mark May downgraded Booking Holdings to Neutral from Buy and lowered his price target for the shares to $2,150 from $2,350. Booking Holding is down over 2% in late morning trading. JPMORGAN CUTS CAMPBELL SOUP TO UNDERWEIGHT: JPMorgan analyst Ken Goldman downgraded Campbell Soup (CPB) to Underweight from Neutral with a $36 price target, saying he believes a sale of the company at a significant premium is unlikely. Campbell Soup is down over 2% in late morning trading. CANTOR SEES MANY REASONS FOR UNITEDHEALTH ACQUIRING ATHENAHEALTH: Numerous media sources cited a Dealreporter story indicating that UnitedHealth (UNH) is now in the second round of bidding for Athenahealth (ATHN), Cantor Fitzgerald analyst Steven Halper said in a research note. There are "many reasons" why UnitedHealth's Optum would benefit from the acquisition of Athenahealth, the analyst contended. With or without the deal, the analyst expects UnitedHealth will deploy capital and grow its various Optum businesses over time. He reiterated an Overweight rating on shares with a $300 price target.
AAOI Applied Optoelectronics
$42.34

-0.16 (-0.38%)

08/08/18
LOOP
08/08/18
NO CHANGE
Target $45
LOOP
Hold
Applied Optoelectronics price target raised to $45 from $32 at Loop Capital
Loop Capital analyst James Kisner raised his price target on Applied Optoelectronics to $45 after its "strong" Q2 results showed a surge in 100G data center revenue, even though its Q3 guidance was "somewhat mixed and impacted by new testing requirements". The analyst also cites the company's ability to maintain relatively high margin within a competitive environment, but keeps a Hold rating on the stock, calling for a longer history of exceeding expectations.
08/08/18
NEED
08/08/18
DOWNGRADE
NEED
Buy
Applied Optoelectronics downgraded to Buy from Strong Buy at Needham
08/08/18
NEED
08/08/18
DOWNGRADE
Target $55
NEED
Buy
Applied Optoelectronics downgraded to Buy at Needham on valuation
As reported earlier, Needham analyst Alex Henderson downgraded Applied Optoelectronics to Buy from Strong Buy but raised his price target to $55 from $44 after its Q2 earnings beat and strong outlook for the second half of 2018. The analyst cites the rising revenue component of its 100G sales diminishing the bear thesis, with forecasted 100G volume expected to double in 2019 from 2018. Henderson also notes the management's view of normal pricing trends, with cost reduction expected to offset price declines in the second half of the year. The analyst notes however that after a 27% rise in the stock price afterhours, there is little upside to justify the Strong Buy rating.
08/08/18
CHLM
08/08/18
NO CHANGE
Target $28
CHLM
Sell
Applied Optoelectronics price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $28 from $20 following a "strong" Q2 result, driven by strong upside from Data Center, specifically Facebook (FB). The analyst thinks most of the upside was from lack of supply from a competitor he believes to be Intel (INTC). He reiterates a Sell rating on Applied Optoelectronics shares.

TODAY'S FREE FLY STORIES

OSK

Oshkosh

$66.69

-1.38 (-2.03%)

07:40
12/10/18
12/10
07:40
12/10/18
07:40
Conference/Events
Oshkosh management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NOVN

Novan

$1.40

0.075 (5.68%)

07:40
12/10/18
12/10
07:40
12/10/18
07:40
Hot Stocks
Novan announces results from Phase 2 SB206 trial »

Novan announced full top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMD

ResMed

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Upgrade
ResMed rating change  »

ResMed upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

07:38
12/10/18
12/10
07:38
12/10/18
07:38
Recommendations
Gilead analyst commentary  »

Gilead landing Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGEN

Compugen

$3.30

-0.16 (-4.62%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Compugen management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MNLO

Menlo Therapeutics

$5.69

0.13 (2.34%)

07:37
12/10/18
12/10
07:37
12/10/18
07:37
Conference/Events
Menlo Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

EBIX

Ebix

$47.17

0.24 (0.51%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Hot Stocks
Ebix division to provide foreign exchange services at India airport »

Ebix announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

NRG

NRG Energy

$40.53

-0.01 (-0.02%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Recommendations
NRG Energy analyst commentary  »

NRG Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROX

Tronox

$7.30

-0.4 (-5.19%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Hot Stocks
Tronox confirms decision by FTC judge regarding pending Cristal acquisition »

Tronox confirmed receipt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCMP

Cabot Microelectronics

$96.77

-4.7 (-4.63%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Conference/Events
Cabot Microelectronics management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$168.37

-6.37 (-3.65%)

, BAC

Bank of America

$25.43

-0.86 (-3.27%)

07:35
12/10/18
12/10
07:35
12/10/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$168.37

-6.37 (-3.65%)

BAC

Bank of America

$25.43

-0.86 (-3.27%)

ATVI

Activision Blizzard

$47.21

-0.94 (-1.95%)

ET

Energy Transfer LP

$14.26

0.03 (0.21%)

DE

Deere

$147.27

-7.01 (-4.54%)

QD

Qudian

$4.97

-0.04 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

COP

ConocoPhillips

$65.93

-0.68 (-1.02%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Hot Stocks
ConocoPhillips sets FY19 CapEx budget of $6.1B »

ConocoPhillips has set a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SKY

Skyline

$17.59

-0.67 (-3.67%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Conference/Events
Skyline management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

PG

Procter & Gamble

$92.45

-1.08 (-1.15%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Recommendations
Procter & Gamble analyst commentary  »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

SMLP

Summit Midstream

$12.72

-0.05 (-0.39%)

07:33
12/10/18
12/10
07:33
12/10/18
07:33
Hot Stocks
Summit Midstream CFO Matthew Harrison to depart »

Summit Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$65.93

-0.68 (-1.02%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
ConocoPhillips sees 2019 production of 1,300-1,350 MBOED »

ConocoPhillips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ONTX

Onconova

$3.47

-0.29 (-7.71%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
Onconova names Avi Oler as VP, corporate development and general counsel »

Onconova Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MITK

Mitek Systems

$8.98

-0.12 (-1.32%)

07:32
12/10/18
12/10
07:32
12/10/18
07:32
Hot Stocks
ASG Technologies increases offer to $11.50 per share to acquire Mitek Systems »

ASG Technologies made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$6.00

-0.1 (-1.64%)

07:31
12/10/18
12/10
07:31
12/10/18
07:31
Upgrade
Synchronoss rating change  »

Synchronoss upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$26.99

-0.62 (-2.25%)

, SPLK

Splunk

$105.70

-5.43 (-4.89%)

07:30
12/10/18
12/10
07:30
12/10/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPS

Gap

$26.99

-0.62 (-2.25%)

SPLK

Splunk

$105.70

-5.43 (-4.89%)

ON

ON Semiconductor

$17.37

-0.91 (-4.98%)

AEO

American Eagle

$18.96

-0.81 (-4.10%)

EQT

EQT Corporation

$18.42

0.41 (2.28%)

NYT

New York Times

$25.11

-0.8 (-3.09%)

TER

Teradyne

$32.60

-1.18 (-3.49%)

USAT

USA Technologies

$4.22

-0.18 (-4.09%)

KAR

KAR Auction

$51.04

-3.17 (-5.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

  • 03

    Mar

  • 08

    May

AUY

Yamana Gold

$2.26

0.075 (3.43%)

07:29
12/10/18
12/10
07:29
12/10/18
07:29
Downgrade
Yamana Gold rating change  »

Yamana Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCM

R1 RCM

$8.71

-0.31 (-3.44%)

07:29
12/10/18
12/10
07:29
12/10/18
07:29
Initiation
R1 RCM initiated  »

R1 RCM initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$137.42

-2.14 (-1.53%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Recommendations
Facebook analyst commentary  »

Facebook valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$10.82

0.2 (1.88%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Hot Stocks
Voyager Therapeutics doses first patient in RESTORE-1 trial »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$27.56

-1.85 (-6.29%)

07:26
12/10/18
12/10
07:26
12/10/18
07:26
Conference/Events
Vanda Pharmaceuticals to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.